Latest News in the pharma Industry

Research & Development

Latest Antibiotic for Clostridium Difficile Significantly Reduces Recurrence of the Infection by 74% Versus Standard of Care

Latest Antibiotic for Clostridium Difficile Significantly Reduces Recurrence of the Infection by 74% Versus Standard of Care

26 Nov 2014

Read more 
BMS  Receives Complete Response Letter from FDA for Daclatasvir, an Investigational Treatment for Hepatitis C

BMS Receives Complete Response Letter from FDA for Daclatasvir, an Investigational Treatment for Hepatitis C

26 Nov 2014

Read more 
NTU Develops Novel 2-in-1 Biomarker and Drug Delivery System

NTU Develops Novel 2-in-1 Biomarker and Drug Delivery System

26 Nov 2014

Read more 
Computer Model Sets New Precedent in Drug Discovery

Computer Model Sets New Precedent in Drug Discovery

25 Nov 2014

Read more 
Nintedanib Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis

Nintedanib Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis

25 Nov 2014

Read more 
Amgen Terminates All Amgen-Sponsored Clinical Studies of Rilotumumab in Advanced Gastric Cancer

Amgen Terminates All Amgen-Sponsored Clinical Studies of Rilotumumab in Advanced Gastric Cancer

24 Nov 2014

Read more 
Novartis Cosentyx Receives Positive CHMP Opinion for First-Line Treatment of Moderate-to-Severe Psoriasis Patients?

Novartis Cosentyx Receives Positive CHMP Opinion for First-Line Treatment of Moderate-to-Severe Psoriasis Patients?

21 Nov 2014

Read more 
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

20 Nov 2014

Read more 
Regeneron and Sanofi Announce New Results from Six Phase III Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

Regeneron and Sanofi Announce New Results from Six Phase III Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

19 Nov 2014

Read more 
Two Drugs are No More Effective than One to Treat Common Kidney Disease

Two Drugs are No More Effective than One to Treat Common Kidney Disease

19 Nov 2014

Read more 
Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases

Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases

18 Nov 2014

Read more 
Nine New Analyses Show Novartis' LCZ696 Could Change Course of Heart Failure for Patients

Nine New Analyses Show Novartis' LCZ696 Could Change Course of Heart Failure for Patients

18 Nov 2014

Read more